Special Issue "Angiogenesis in Cancer"
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: 15 November 2019.
Angiogenesis is a coordinated cascade of numerous complex cellular processes, including endothelial cell migration, proliferation, sprouting, and lumen formation, which ultimately leads to the formation of new vessels. These coordinated cellular events are regulated by various cell surface receptors and soluble ligands. The ability of endothelial cells to form capillary tubes is a prerequisite for the establishment of a continuous vessel lumen that routes the blood flow. Several key receptor tyrosine kinases, such as vascular endothelial growth factor (VEGF) receptor-1 (VEGFR-1), VEGFR-2, and VEGFR-3, and cell adhesion molecules (CAMs), including cadherins, integrins, selectins, immunoglobulin (Ig) superfamily proteins, and Notch receptors, are involved in the regulation of angiogenesis. Moreover, various post-translational modifications, including phosphorylation, methylation, ubiquitination, and glycosylation, play integral roles in the various aspects of angiogenesis. This Special Issue of Cells brings together the most recent advances in various aspects of angiogenesis, from basic science to applied therapeutic angiogenesis and will provide new insights into our understanding of angiogenesis.
Prof. Nader Rahimi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- molecular mechanisms of tumor angiogenesis
- post-translational modification and tumor angiogenesis
- cell adhesion molecules and tumor angiogenesis
- mechanotransduction signaling and angiogenesis
- anti-angiogenesis therapy of cancer
- metabolism and angiogenesis
- therapeutic angiogenesis and beyond
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Author: Felisbina Queiroga
Tentative Title: Crosstalk between TGFβ, FoxP3 and angiogenesis in malignant canine mammary tumors: association with clinicopathological parameters and prognosis
Author: Ugo Cavallaro
Tentative Title: L1CAM and its multiple ways to (dys)regulate cancer vasculature
Author: Wen-Hui Fang, Mark Slevin and Shant Kumar
Tentative Title: The angiogenic activities of HIV-1 matrix protein p17 could contribute to AIDS-related lymphomasAuthor: Lei Xu
Affiliation: Steele lab at Mass General Hospital, Harvard Medical School
Tentative Title: Vasculogenic mimicry in head and neck cancersAuthor: József Jászai1, Mirko HH Schmidt2
Tentative Title: Trends and challenges in tumor anti-angiogenic therapiesAuthor: Giuseppe Esposito
Tentative title: Antiangiogenic effect of rifaximin in human colon cancer organotypic coltures
Tentative title: Gene expression heterogeneity of Platelet Derived Growth Factor pathway defines three distinct subgroups in renal cell carcinomasAuthors: Hotaka Kawai, Takanori Eguchi*, Hitoshi Nagatsuka
Tentative Title: Antagonizing CXCR4 declines intra-tumoral angiogenesis and induces tumor necrosis in oral cancer
Authors: Dongmei Zhang
Tentative Title: Tumor vascular targeting strategy: A double-sward in tumor metastasis